Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2682622rdf:typepubmed:Citationlld:pubmed
pubmed-article:2682622lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:2682622lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2682622lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2682622lifeskim:mentionsumls-concept:C0003601lld:lifeskim
pubmed-article:2682622lifeskim:mentionsumls-concept:C0163314lld:lifeskim
pubmed-article:2682622lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:2682622pubmed:issue20lld:pubmed
pubmed-article:2682622pubmed:dateCreated1989-12-1lld:pubmed
pubmed-article:2682622pubmed:abstractTextRat intestinal fatty acid binding protein (I-FABP) is a member of a family of cytoplasmic hydrophobic ligand-binding proteins. To gain insights about the contribution of bound fatty acid to I-FABP's conformation and mechanism of ligand binding, we have determined the structure of Escherichia coli-derived rat apo-I-FABP to 1.96-A resolution and compared it to the recently refined structure of I-FABP with bound palmitate. Both apo- and holo-I-FABP are composed primarily of anti-parallel beta-strands which form two nearly orthogonal beta-sheets ("beta-clam"). The overall structures of the apo- and holo-I-FABP are nearly identical, with a root mean square (rms) difference of 0.37 A between C alpha atoms, 0.38 A between all main-chain atoms, and 0.94 A between all side-chain atoms. However, rms differences of greater than 1.3 A were noted for the side chains of Ile-23, Lys-27, Arg-56, Leu-72, Ala-73, and Asp-74. The space occupied by bound ligand in the core of the holoprotein is occupied in the apo-protein by ordered solvent molecules. This results in an increase in the total number of internal ordered solvent molecules from 7 in the holoprotein to 13 in apo-I-FABP. This finding, together with observed differences in the side-chain orientations of two residues (Arg-56 and Lys-27) situated over a potential opening to the cores of the apo- and holoproteins, suggests that solvent molecules play a critical role in ligand binding. Moreover, the data indicate that the beta-clam structure is stable even in the absence of bound ligand.lld:pubmed
pubmed-article:2682622pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:languageenglld:pubmed
pubmed-article:2682622pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:citationSubsetIMlld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2682622pubmed:statusMEDLINElld:pubmed
pubmed-article:2682622pubmed:monthOctlld:pubmed
pubmed-article:2682622pubmed:issn0027-8424lld:pubmed
pubmed-article:2682622pubmed:authorpubmed-author:GordonJ IJIlld:pubmed
pubmed-article:2682622pubmed:authorpubmed-author:BanaszakL JLJlld:pubmed
pubmed-article:2682622pubmed:authorpubmed-author:SacchettiniJ...lld:pubmed
pubmed-article:2682622pubmed:issnTypePrintlld:pubmed
pubmed-article:2682622pubmed:volume86lld:pubmed
pubmed-article:2682622pubmed:ownerNLMlld:pubmed
pubmed-article:2682622pubmed:authorsCompleteYlld:pubmed
pubmed-article:2682622pubmed:pagination7736-40lld:pubmed
pubmed-article:2682622pubmed:dateRevised2010-9-9lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:meshHeadingpubmed-meshheading:2682622-...lld:pubmed
pubmed-article:2682622pubmed:year1989lld:pubmed
pubmed-article:2682622pubmed:articleTitleRefined apoprotein structure of rat intestinal fatty acid binding protein produced in Escherichia coli.lld:pubmed
pubmed-article:2682622pubmed:affiliationDepartment of Biochemistry, Washington University School of Medicine, Saint Louis, MO 63110.lld:pubmed
pubmed-article:2682622pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2682622pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2682622pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:25598entrezgene:pubmedpubmed-article:2682622lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2682622lld:pubmed